» Authors » George Zahariadis

George Zahariadis

Explore the profile of George Zahariadis including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 47
Citations 939
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Meilleur C, Zhou J, Hoang L, Tyrrell G, Minion J, Van Caeseele P, et al.
J Med Microbiol . 2025 Mar; 74(3). PMID: 40071600
Invasive meningococcal disease (IMD) is a nationally notifiable illness in Canada due to its potential severity and transmissibility. Vaccination strategies differ by province/territory and are informed by changes in the...
2.
Wilke M, Mistry K, Thumbi D, Li X, Charlebois A, Cormier A, et al.
Can J Microbiol . 2025 Mar; PMID: 40030142
Ciprofloxacin is important for treatment of severe or invasive Salmonella infections in humans. As laboratories transition from phenotypic to genomics-based methods for determining ciprofloxacin non-susceptibility, it is important to define...
3.
Fell D, Russell M, Fung S, Swayze S, Chung H, Buchan S, et al.
J Infect Dis . 2024 Jul; 230(1):e80-e92. PMID: 39052720
Background: Randomized trials conducted in low- and middle-income settings demonstrated efficacy of influenza vaccination during pregnancy against influenza infection among infants <6 months of age. However, vaccine effectiveness (VE) estimates...
4.
Chung H, Campitelli M, Buchan S, Campigotto A, Crowcroft N, Gubbay J, et al.
Euro Surveill . 2024 Feb; 29(8). PMID: 38390652
BackgroundWaning immunity from seasonal influenza vaccination can cause suboptimal protection during peak influenza activity. However, vaccine effectiveness studies assessing waning immunity using vaccinated and unvaccinated individuals are subject to biases.AimWe...
5.
Golden A, Griffith A, Demczuk W, Lefebvre B, McGeer A, Tyrrell G, et al.
Can Commun Dis Rep . 2023 Dec; 48(9):396-406. PMID: 38124782
Background: Invasive pneumococcal disease (IPD), which is caused by , has been a nationally notifiable disease in Canada since 2000. The use of conjugate vaccines has markedly decreased the incidence...
6.
Golden A, Griffith A, Demczuk W, Tyrrell G, Kus J, McGeer A, et al.
Can Commun Dis Rep . 2023 Dec; 48(9):407-414. PMID: 38106647
Background: Invasive group A streptococcal (iGAS) disease (caused by ) has been a nationally notifiable disease in Canada since 2000. This report summarizes the demographics, types and antimicrobial resistance of...
7.
Buchan S, Chung H, To T, Daneman N, Guttmann A, Kwong J, et al.
J Pediatric Infect Dis Soc . 2023 Jun; 12(7):421-430. PMID: 37335754
Background: Respiratory syncytial virus (RSV) contributes significantly to morbidity in children, placing substantial burdens on health systems, thus RSV vaccine development and program implementation are a public health priority. More...
8.
Atkinson A, Albert A, McClymont E, Andrade J, Beach L, Bolotin S, et al.
CMAJ Open . 2023 Apr; 11(2):E305-E313. PMID: 37015743
Background: Insufficient data on the rate and distribution of SARS-CoV-2 infection in Canada has presented a substantial challenge to the public health response to the COVID-19 pandemic. Our objective was...
9.
Chung H, Campitelli M, Buchan S, Campigotto A, Chen B, Crowcroft N, et al.
Clin Infect Dis . 2023 Mar; 77(2):303-311. PMID: 36942534
Background: Older adults are recommended to receive influenza vaccination annually, and many use statins. Statins have immunomodulatory properties that might modify influenza vaccine effectiveness (VE) and alter influenza infection risk....
10.
Tsang R, Law D, Zhou J, Haldane D, Garceau R, Zahariadis G, et al.
J Med Microbiol . 2023 Feb; 71(12). PMID: 36748536
Invasive meningococcal disease (IMD) caused by may show temporal and geographical changes in both the epidemiology and the characteristics of the strains involved. A study that examined invasive causing IMD...